Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

October 2027 112

  1. Primary completion Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07747402

  2. Study completion A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07783802

  3. Study completion Transcutaneous Regulation for Atrial Prevention in Postoperative Atrial Fibrillation Following OPCAB Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07824492

  4. Primary completion Transcutaneous Regulation for Atrial Prevention in Postoperative Atrial Fibrillation Following OPCAB Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07824492

  5. Primary completion REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07834372

  6. Study completion A Study to Evaluate Efficacy and Safety of GW906 Used as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by One or Two Antihypertensive Medications Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07835984

  7. Primary completion A Study to Evaluate Efficacy and Safety of GW906 Used as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by One or Two Antihypertensive Medications Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07835984

  8. Study start Aspirin for the Prevention of Ischemic Complications in Giant Cell Arteritis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07908082

  9. Primary completion Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07920939

  10. Study completion A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07361302

  11. Primary completion A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07361302

  12. Primary completion A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07668388

  13. Primary completion QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07444086

  14. Primary completion A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07647133

  15. Primary completion The ENCIRCLE Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04153292

  16. Study completion A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07930507

  17. Primary completion A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07930507

  18. Primary completion A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07400653

  19. Study completion Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04184635

  20. Primary completion Flow-diverting Devices for the Treatment of Middle Cerebral Artery Bifurcation Aneurysms Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07372612

  21. Study completion Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke Unit Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07670065

  22. Study completion A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07796477

  23. Study completion A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07755150

  24. Primary completion A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07755150

  25. Study completion Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Diet and Exercise Alone(UNIGUIDE-1) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07659574

  26. Study completion Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03892824

  27. Study completion Impact of Metformin on Peripheral Arterial Calcification in Type 1 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04583462

  28. Study completion The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03129490

  29. Primary completion The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03129490

  30. Primary completion the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05126446

  31. Primary completion Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05949008

  32. Primary completion Parent Artery Reconstruction for Small Unruptured Cerebral Aneurusms Using Flow DiverTers: a Multicenter Randomized Trial(PARAT-MT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06600997

  33. Study completion DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06657833

  34. Primary completion DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06657833

  35. Primary completion Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07032311

  36. Primary completion Vascular Trial Associated Registry Pilot Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07076082

  37. Study completion Clinical Prospective ranDomized Trial to Evaluate the Non-inferiority of Left Bundle Branch Area Pacing Vs Cardiac ResynchronIzatioN Therapy With ECG guIded AV Optimization Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07107048

  38. Primary completion Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07115953

  39. Study completion Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07405216

  40. Primary completion A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07660796

  41. Study completion Reducing Lung CongestIon Symptoms in Advanced Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03499236

  42. Study completion Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05553093

  43. Primary completion Brain-Oscillation-Synchronized Stimulation to Enhance Motor Recovery in Early Subacute Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05600374

  44. Primary completion Stroke Alarm Efficacy Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06315192

  45. Study completion Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06435156

  46. Primary completion Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06435156

  47. Primary completion The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06861088

  48. Primary completion STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06901466

  49. Study completion PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06915792

  50. Study completion Efficacy and Safety of Xinyue Capsule in the Treatment of Heart Failure With Preserved Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06946095

  51. Primary completion Efficacy and Safety of Xinyue Capsule in the Treatment of Heart Failure With Preserved Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06946095

  52. Primary completion Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06987305

  53. Study completion Post-Market Study of ZENFLEX Pro Stent for Femoropopliteal Artery Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07049120

  54. Study completion A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07054541

  55. Primary completion A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07054541

  56. Study completion Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07311343

  57. Study completion Grid eXplore Mapping Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07421076

  58. Primary completion Effect of Finerenone on Myocardial Fibrosis and Cardiac Function in HFmrEF/HFpEF Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07583173

  59. Primary completion Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07667517

  60. Primary completion AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07697391

  61. Primary completion RDN for CKD and Uncontrolled Hypertension Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07945795

November 2027 87

  1. Study completion Evaluating Edge-to-edge Transcatheter Tricuspid Valve Repair in Patients With Severe Symptomatic Tricuspid Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05628779

  2. Primary completion Evaluating Edge-to-edge Transcatheter Tricuspid Valve Repair in Patients With Severe Symptomatic Tricuspid Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05628779

  3. Study completion Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06049654

  4. Primary completion Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06049654

  5. Primary completion Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06095765

  6. Study completion Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07073469

  7. Primary completion Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAL-119 in Healthy Volunteers and Adult Participants With Type 1 or Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07901595

  8. Study completion Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02922036

  9. Primary completion Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02922036

  10. Primary completion Rituximab in Patients With ST-elevation Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05211401

  11. Study completion A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05433584

  12. Study completion Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05983757

  13. Primary completion A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06008197

  14. Study completion A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06024746

  15. Primary completion A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06024746

  16. Study completion Narrative Intervention for Chronic Illness- Heart Failure Trial (NICI-HF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06097481

  17. Primary completion Narrative Intervention for Chronic Illness- Heart Failure Trial (NICI-HF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06097481

  18. Primary completion A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06305559

  19. Primary completion The PERSEVERE Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06588634

  20. Primary completion Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06767345

  21. Study completion Formoterol in Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07022418

  22. Primary completion Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07028749

  23. Study completion CGM Use in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07045298

  24. Primary completion CGM Use in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07045298

  25. Primary completion A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07078383

  26. Primary completion CGM Use in Non-insulin Patients With DM2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07128342

  27. Study completion AI-Guided Left Bundle Branch Area Pacing Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07206602

  28. Primary completion AI-Guided Left Bundle Branch Area Pacing Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07206602

  29. Study completion Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07296744

  30. Primary completion Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07296744

  31. Primary completion A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07379333

  32. Study completion Trial of CGM Technology in Persons Living With Prediabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07639593

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion Decalcification of the Aortic Valve by Vitamin K2 (Menaquinone-7) Registry record

    Expected 2020-12; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03305536

  2. Primary completion Decalcification of the Aortic Valve by Vitamin K2 (Menaquinone-7) Registry record

    Expected 2020-12; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03305536

  3. Study completion Stem Cell Educator Therapy in Diabetes Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03390231

  4. Study completion TEC4Home Heart Failure: Using Home Health Monitoring to Support the Transition of Care Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03439384

  5. Study completion Intensive Insulin for Severe/Moderate Hypertriglyceridemia Pancreatitis. Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03501680

  6. Study completion Neuroprotectant for Hypertensive Intracerebral Hemorrhage Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03546283

  7. Primary completion VitaFlowTM II Transcatheter Aortic Valve System Study Registry record

    Expected 2020-12; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03575039

  8. Study completion Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03587558

  9. Study completion Surgical Revascularization Outcomes After Oral Anticoagulation or Antiplatelets Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03605433

  10. Study completion Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03620760

  11. Primary completion Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03620760

  12. Primary completion Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03658031

  13. Study completion Janagliflozin Treat T2DM Monotherapy Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03811548

  14. Study completion Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH) Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03844594

  15. Study completion Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03882775

  16. Primary completion Efficacy and Safety of Sotalol in Children With Arrhythmia Registry record

    Expected 2020-12; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03895411

  17. Study completion Strategy for Aortic Surgery Hemostasis Registry record

    Expected 2020-12; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03917862

  18. Primary completion Strategy for Aortic Surgery Hemostasis Registry record

    Expected 2020-12; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03917862

  19. Study completion Ivabradine to Prevent Anthracycline-induced Cardiotoxicity Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04030546

  20. Study completion Progesterone in the Treatment of Acute Hemorrhagic Stroke Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04143880

  21. Study completion Multicenter Study on the Efficacy of Transcranial Direct Current Stimulation (tDCS) in Post-stroke Motor Recovery Registry record

    Expected 2020-12; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04166968

  22. Primary completion Multicenter Study on the Efficacy of Transcranial Direct Current Stimulation (tDCS) in Post-stroke Motor Recovery Registry record

    Expected 2020-12; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04166968

  23. Primary completion Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban Registry record

    Expected 2020-12; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04169269

  24. Study completion Bivalirudin in Late PCI for Oatients With STEMI Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04185077

  25. Primary completion Bivalirudin in Late PCI for Oatients With STEMI Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04185077

  26. Study start Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris Registry record

    Expected 2020-12; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04270279

  27. Study completion Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection Fraction Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04308031

  28. Primary completion Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection Fraction Registry record

    Expected 2020-12-31; that period ended on 2020-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04308031

  29. Study start Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome Registry record

    Expected 2021-01-01; that period ended on 2021-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04100434

  30. Study start Lovastatin for Treatment of Brain Arteriovenous Malformations Registry record

    Expected 2021-01-01; that period ended on 2021-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04297033

  31. Study start 3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI Registry record

    Expected 2021-01-01; that period ended on 2021-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04570345

  32. Study start Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography Registry record

    Expected 2021-01-01; that period ended on 2021-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04664283

  33. Study completion The Effect of a Self-rehabilitation Program in Addition to Usual Treatment for Spasticity on Impairment and Activity Limitation in Patients With Spastic Hemiparesis Following Stroke Registry record

    Expected 2021-01-03; that period ended on 2021-01-03.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02944929

  34. Study completion Local Anesthesia in Radial Catheterization Registry record

    Expected 2021-01-10; that period ended on 2021-01-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03072394

  35. Study completion Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes Registry record

    Expected 2021-01-15; that period ended on 2021-01-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03058029

  36. Primary completion Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes Registry record

    Expected 2021-01-15; that period ended on 2021-01-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03058029

  37. Study start Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction Registry record

    Expected 2021-01-15; that period ended on 2021-01-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04695990

  38. Study completion Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation Registry record

    Expected 2021-01-19; that period ended on 2021-01-19.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02053038

  39. Primary completion Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation Registry record

    Expected 2021-01-19; that period ended on 2021-01-19.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02053038

  40. Primary completion Second-generation Drug-eluting Stents in Diabetes Registry record

    Expected 2021-01-28; that period ended on 2021-01-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03321032

  41. Study completion Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic Activity Registry record

    Expected 2021-01; that period ended on 2021-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01888315

  42. Primary completion Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic Activity Registry record

    Expected 2021-01; that period ended on 2021-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01888315

  43. Study completion Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction Registry record

    Expected 2021-01-31; that period ended on 2021-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03658031

  44. Primary completion Augmenting Cerebral Blood Flow to Preserve the Penumbra Trial Registry record

    Expected 2021-01; that period ended on 2021-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04014621

  45. Study start Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy Registry record

    Expected 2021-01; that period ended on 2021-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04667143

  46. Study completion Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent Registry record

    Expected 2021-02-01; that period ended on 2021-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01879358

  47. Study start Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Registry record

    Expected 2021-02-01; that period ended on 2021-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04686643

  48. Study start A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin Registry record

    Expected 2021-02-01; that period ended on 2021-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04706637

  49. Study start Low-volume vs High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis Registry record

    Expected 2021-02-01; that period ended on 2021-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04709770

  50. Study start Use of Glidesheath Slender to Reduce Radial Artery Occlusion Following 7 French Transradial Coronary Intervention Registry record

    Expected 2021-02-01; that period ended on 2021-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04748068

  51. Study start Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI Registry record

    Expected 2021-02-20; that period ended on 2021-02-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04754789

  52. Study completion Study of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or Occlusion Registry record

    Expected 2021-02; that period ended on 2021-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03121430

  53. Primary completion Perioperative Continuation of Metformin Therapy in Patients With Typ 2 Diabetes Mellitus Undergoing Non-cardiac Surgery Registry record

    Expected 2021-02; that period ended on 2021-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04284722

  54. Study completion Effect of Atorvastatin on Carotid Intima Media Thickness Registry record

    Expected 2021-02-28; that period ended on 2021-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04306627

  55. Study start Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions Registry record

    Expected 2021-02; that period ended on 2021-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04744571

  56. Study start Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507 Registry record

    Expected 2021-02; that period ended on 2021-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04772443

  57. Study start A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Registry record

    Expected 2021-03-01; that period ended on 2021-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04179045

  58. Study start Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris Registry record

    Expected 2021-03-01; that period ended on 2021-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04661709

  59. Study start Edaravone Dexborneol for Treatment of Hypertensive Intracerebral Hemorrhage Registry record

    Expected 2021-03-01; that period ended on 2021-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04714177

  60. Study completion Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI Registry record

    Expected 2021-03-01; that period ended on 2021-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04754789

  61. Primary completion Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI Registry record

    Expected 2021-03-01; that period ended on 2021-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04754789

  62. Study completion Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents Registry record

    Expected 2021-03-02; that period ended on 2021-03-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04287387

  63. Primary completion Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents Registry record

    Expected 2021-03-02; that period ended on 2021-03-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04287387

  64. Study start Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial Registry record

    Expected 2021-03-02; that period ended on 2021-03-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04696120

  65. Study completion Local Thrombolytics Before Thrombectomy in STEMI Registry record

    Expected 2021-03; that period ended on 2021-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01568931

  66. Study completion LEADERS FREE II: BioFreedom™ Pivotal Study Registry record

    Expected 2021-03; that period ended on 2021-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02843633

  67. Study completion BioFreedom QCA Study in CAD Patients Registry record

    Expected 2021-03-31; that period ended on 2021-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03307213

  68. Study completion Study With an Innovative Equipment to Monitor and Control SALT During Cooking Registry record

    Expected 2021-03-31; that period ended on 2021-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03974477

  69. Primary completion Study With an Innovative Equipment to Monitor and Control SALT During Cooking Registry record

    Expected 2021-03-31; that period ended on 2021-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03974477

  70. Study completion A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke. Registry record

    Expected 2021-03-31; that period ended on 2021-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04028518

  71. Study start A Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease The CAD-det Validation Study Registry record

    Expected 2021-03; that period ended on 2021-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04562142

  72. Primary completion Stand Up Kansas: An Intervention to Reduce Sedentary Behavior in the Home Work Environment Registry record

    Expected 2021-03; that period ended on 2021-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04641689

  73. Primary completion Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology Registry record

    Expected 2021-04-20; that period ended on 2021-04-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03917563

  74. Study completion A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure Registry record

    Expected 2021-04-20; that period ended on 2021-04-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03941691

  75. Primary completion A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure Registry record

    Expected 2021-04-20; that period ended on 2021-04-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03941691

  76. Study completion The Safety and Efficacy of AVI Stent for Treating Coronary Revascularization Registry record

    Expected 2021-04; that period ended on 2021-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02117843

  77. Study completion Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions Registry record

    Expected 2021-04; that period ended on 2021-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02360423

  78. Study completion SecOnd-generation seLf-expandable Versus Balloon-expandable Valves and gEneral Versus Local Anesthesia in TAVI Registry record

    Expected 2021-04; that period ended on 2021-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02737150

  79. Study completion Effects of Fenofibrate Therapy in Diabetic Nephropathy Registry record

    Expected 2021-04-30; that period ended on 2021-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03869931

  80. Primary completion Effects of Fenofibrate Therapy in Diabetic Nephropathy Registry record

    Expected 2021-04-30; that period ended on 2021-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03869931

  81. Study completion Augmenting Cerebral Blood Flow to Preserve the Penumbra Trial Registry record

    Expected 2021-04; that period ended on 2021-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04014621

  82. Primary completion Influence of the PEPA Membrane on the Undernutrition Syndrome Inflammation in Chronic Hemodialysis Registry record

    Expected 2021-04; that period ended on 2021-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04185571

  83. Study completion Perioperative Continuation of Metformin Therapy in Patients With Typ 2 Diabetes Mellitus Undergoing Non-cardiac Surgery Registry record

    Expected 2021-04; that period ended on 2021-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04284722

  84. Study completion Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet Registry record

    Expected 2021-04; that period ended on 2021-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04388215

  85. Primary completion Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet Registry record

    Expected 2021-04; that period ended on 2021-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04388215

  86. Study start Randomized Study of Beta-Blockers and Antiplatelets in Patients With Spontaneous Coronary Artery Dissection Registry record

    Expected 2021-04-30; that period ended on 2021-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04850417

  87. Primary completion Early Treatment of ARNI on Myocardial Remodeling and Progress Registry record

    Expected 2021-05-01; that period ended on 2021-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04342351

  88. Study start Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome Registry record

    Expected 2021-05-01; that period ended on 2021-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04814121

  89. Primary completion Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure Registry record

    Expected 2021-05-15; that period ended on 2021-05-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02137187

  90. Study completion EVALECGcardio Study Registry record

    Expected 2021-05-21; that period ended on 2021-05-21.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04468477

  91. Primary completion EVALECGcardio Study Registry record

    Expected 2021-05-21; that period ended on 2021-05-21.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04468477

  92. Primary completion Evidence-based Evaluation of TCM Key Syndrome Differentiation and Treatment for Acute Ischemic Stroke Registry record

    Expected 2021-05-30; that period ended on 2021-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04199455

  93. Primary completion Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy Registry record

    Expected 2021-05; that period ended on 2021-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02594501

  94. Study completion Antioxidant and NMDA Receptor Blocker Wins Anoxic Brain Damage of KorEa OHCA Patients Registry record

    Expected 2021-05; that period ended on 2021-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03651557

  95. Primary completion Antioxidant and NMDA Receptor Blocker Wins Anoxic Brain Damage of KorEa OHCA Patients Registry record

    Expected 2021-05; that period ended on 2021-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03651557

  96. Primary completion OPtimisation of Surgical Repair for Treating Insufficiency of the MItral Valve - Safety and Effectiveness Evaluation Registry record

    Expected 2021-05-31; that period ended on 2021-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03908983

  97. Study completion Effectiveness of Stroke Riskometer Apps In Improving Awareness and Stroke Risk Probability Registry record

    Expected 2021-05; that period ended on 2021-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04529681

  98. Primary completion Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial Aneurysms Registry record

    Expected 2021-05; that period ended on 2021-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04532333

  99. Study completion Use of Glidesheath Slender to Reduce Radial Artery Occlusion Following 7 French Transradial Coronary Intervention Registry record

    Expected 2021-05-31; that period ended on 2021-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04748068

  100. Primary completion Use of Glidesheath Slender to Reduce Radial Artery Occlusion Following 7 French Transradial Coronary Intervention Registry record

    Expected 2021-05-31; that period ended on 2021-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04748068